Study setting
This study was designed as a single-blind, parallel-group, randomized controlled trial. The study was reviewed and approved by the Institutional Review Board of Wonju Severance Christian Hospital (CR321057; approval date: 20/07/2021) and registered with the Clinical Research Information Service of Korea (KCT0007488; registration date: 30/06/2022). This study was conducted in a tertiary university hospital in Wonju, Republic of Korea. This study was reported in compliance with the Consolidated Standards of Reporting Trials guidelines [